「情報が失われていないか心配だ」住民票のサーバーもダウン 沖縄・北大東島で連日の停電
沖縄県北大東村で16、17の連日、停電が発生した。沖縄電力によると、16日は午前中に全世帯の3分の1以上に当たる120戸が約20分間、17日は午後に90戸が約10分間停電した。原因は調査中。村役場の機能も大部分が止まり、住民票の情報などを管理するネットワークシステムのサーバーが一時ダウンした。村職員の一人は「情報が失われていないか心配だ」と危惧した。 【写真】暑い中クーラーも扇風機も使えず 沖縄・久高島で26時間停電 同村内には沖電の発電所がある。7月14日午前にも発電機の一部が不具合を起こし、110戸が最大で約6時間20分間停電した。翌15日も90戸が最大で約6時間20分停電した。 宮城光正村長は「住民生活に影響が出ている。原因を調査し、再発防止に努めてほしい」と沖電に求めた。（南部報道部・国吉聡志）
WhatsApp работает в браузере Google Chrome 60 и новее
Чтобы пользоваться WhatsApp, обновите Chrome или используйте Mozilla Firefox, Safari, Microsoft Edge или Opera.
WhatsApp работает в браузере Google Chrome 60 и новее
Чтобы пользоваться WhatsApp, обновите Chrome или используйте Mozilla Firefox, Safari, Microsoft Edge или Opera.
FreeSurfer software suite
FreeSurfer is an open source package for the analysis and visualization “90/10”策略介绍 of structural, functional, and diffusion neuroimaging data from cross-sectional and longitudinal studies. It is developed by the Laboratory for Computational Neuroimaging at the Athinoula A. Martinos Center for Biomedical Imaging.
What does it include?
A full processing stream for MR imaging data that involves skull-stripping, bias field correction, registration, and anatomical segmentation as well as cortical surface reconstruction, registration, and parcellation. FreeSurfer also includes fMRI and diffusion tractography toolboxes, a robust “90/10”策略介绍 visualization interface, utilities for statistical group analysis, and much more.
Severely suppressed bone turnover: a potential complication of alendronate therapy
Alendronate, an inhibitor of bone resorption, is widely used in osteoporosis treatment. However, concerns have been raised about potential oversuppression of bone turnover during long-term use. We report on nine patients who sustained spontaneous nonspinal fractures while on alendronate therapy, six of whom displayed either delayed or absent fracture healing for 3 months to 2 yr during therapy. Histomorphometric analysis of the cancellous bone showed markedly suppressed “90/10”策略介绍 bone formation, with reduced or absent osteoblastic surface in most patients. Osteoclastic surface was low or low-normal in eight patients, and eroded surface was decreased in four. Matrix synthesis was markedly diminished, with absence of double-tetracycline label and absent or reduced single-tetracycline label in all patients. The same trend was seen in the intracortical and endocortical surfaces. Our findings raise the possibility that severe suppression of bone turnover may develop during long-term alendronate therapy, resulting in increased susceptibility to, and delayed healing of, nonspinal fractures. Although coadministration of estrogen or glucocorticoids appears to be a predisposing factor, this apparent complication can also occur with monotherapy. Our observations emphasize the need for increased awareness and monitoring for the potential development of excessive “90/10”策略介绍 suppression of bone turnover during long-term alendronate therapy.
Comment in
Ott SM. Ott SM. J Clin Endocrinol Metab. 2005 Mar;90(3):“90/10”策略介绍 1897-9. doi: 10.1210/jc.2005-0057. J Clin Endocrinol Metab. 2005. PMID: 15758064 No abstract available.
Similar articles
Chavassieux PM, Arlot ME, Roux JP, Portero N, Daifotis A, Yates AJ, Hamdy NA, Malice MP, Freedholm D, Meunier PJ. Chavassieux PM, et al. J Bone Miner Res. 2000 Apr;15(4):754-62. doi: “90/10”策略介绍 10.1359/jbmr.2000.15.4.754. J Bone Miner Res. 2000. PMID: 10780867 Clinical Trial.
Armamento-Villareal R, Napoli N, Panwar V, “90/10”策略介绍 Novack D. Armamento-Villareal R, et al. N Engl “90/10”策略介绍 J Med. 2006 Nov 9;355(19):2048-50. doi: 10.1056/NEJMc062268. N Engl J “90/10”策略介绍 Med. 2006. PMID: 17093260 No abstract available.“90/10”策略介绍
Yamaguchi T, Sugimoto T. Yamaguchi T, et al. Clin Calcium. 2009 Jan;19(1):“90/10”策略介绍 “90/10”策略介绍 38-43. Clin Calcium. 2009. PMID: 19122263 Review. Japanese.
Pérez-López FR. Pérez-López FR. Maturitas. 2004 Jul 15;48(3):179-92. doi: 10.1016/j.maturitas.2003.12.006. Maturitas. 2004. PMID: 15207883 Review.
Cited by
Chavassieux P, Chapurlat R. Chavassieux P, et al. Front Endocrinol (Lausanne). 2022 Jul 28;13:907914. doi: 10.3389/fendo.2022.907914. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35966102 Free PMC article. Review.
Patntirapong S. Patntirapong S. J Oral Biol Craniofac Res. 2022 Sep-Oct;12(5):575-579. doi: 10.1016/j.jobcr.2022.07.011. Epub “90/10”策略介绍 2022 Jul 31. J Oral Biol Craniofac Res. 2022. PMID: 35957942 Free PMC article.
Kydonaki EK, Freitas L, Reguengo H, Simón CR, Bastos AR, Fernandes EM, Canadas RF, Oliveira JM, Correlo VM, Reis RL, Vliora M, Gkiata P, Koutedakis Y, Ntina G, Pinto R, Carrillo AE, Marques F, Amorim T. Kydonaki EK, et al. Nutrients. 2022 Jul 11;14(14):2837. doi: 10.3390/nu14142837. Nutrients. 2022. PMID: 35889794 Free PMC article.
Toro G, Braile A, De Cicco A, Pezzella R, Ascione F, Cecere AB, Schiavone Panni A. Toro G, et al. Indian J Orthop. 2022 May 26;56(7):“90/10”策略介绍 1139-1149. doi: 10.1007/s43465-022-00653-0. eCollection 2022 Jul. Indian J Orthop. 2022. PMID: 35813545 Free PMC article. Review.
Golfieri FDC, Zanon M, Percio PPV. Golfieri FDC, et al. Acta Ortop Bras. 2022 Apr 15;30(2):e238821. doi: 10.1590/1413-785220223002238821. eCollection 2022. Acta Ortop Bras. 2022. PMID: 35719180 Free PMC article.